Dale Q Rice Investment Management Ltd Sells 586 Shares of Mastercard Incorporated (NYSE:MA)

Dale Q Rice Investment Management Ltd lowered its stake in Mastercard Incorporated (NYSE:MA) by 9.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,722 shares of the credit services provider’s stock after selling 586 shares during the quarter. Mastercard makes up approximately 1.6% of Dale Q Rice Investment Management Ltd’s investment portfolio, making the stock its 14th largest position. Dale Q Rice Investment Management Ltd’s holdings in Mastercard were worth $3,137,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Dupont Capital Management Corp lifted its holdings in shares of Mastercard by 7.2% in the first quarter. Dupont Capital Management Corp now owns 49,045 shares of the credit services provider’s stock worth $26,883,000 after acquiring an additional 3,288 shares during the last quarter. Rockline Wealth Management LLC lifted its holdings in shares of Mastercard by 6.5% in the first quarter. Rockline Wealth Management LLC now owns 8,335 shares of the credit services provider’s stock worth $4,569,000 after acquiring an additional 507 shares during the last quarter. Evanson Asset Management LLC lifted its holdings in shares of Mastercard by 12.2% in the first quarter. Evanson Asset Management LLC now owns 2,502 shares of the credit services provider’s stock worth $1,372,000 after acquiring an additional 273 shares during the last quarter. Davies Financial Advisors Inc. increased its stake in shares of Mastercard by 1.6% in the first quarter. Davies Financial Advisors Inc. now owns 1,743 shares of the credit services provider’s stock valued at $955,000 after buying an additional 27 shares during the period. Finally, Advisor Resource Council acquired a new position in shares of Mastercard in the first quarter valued at approximately $1,029,000. Institutional investors own 97.28% of the company’s stock.

Insider Buying and Selling

In other Mastercard news, insider Sandra A. Arkell sold 150 shares of the firm’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $580.00, for a total transaction of $87,000.00. Following the transaction, the insider now directly owns 3,255 shares in the company, valued at approximately $1,887,900. This trade represents a 4.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael Miebach sold 15,775 shares of the firm’s stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $550.16, for a total value of $8,678,774.00. Following the sale, the chief executive officer now directly owns 84,871 shares of the company’s stock, valued at approximately $46,692,629.36. This represents a 15.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,513 shares of company stock worth $23,166,463 in the last ninety days. Corporate insiders own 0.09% of the company’s stock.

Wall Street Analysts Forecast Growth

MA has been the subject of several recent research reports. Monness Crespi & Hardt downgraded Mastercard from a “buy” rating to a “neutral” rating in a research note on Wednesday, April 9th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $633.00 price objective on shares of Mastercard in a research note on Wednesday, April 2nd. UBS Group upped their price objective on Mastercard from $660.00 to $670.00 and gave the company a “buy” rating in a research note on Tuesday, June 3rd. Wall Street Zen downgraded Mastercard from a “buy” rating to a “hold” rating in a research note on Saturday, June 14th. Finally, Tigress Financial reaffirmed a “strong-buy” rating on shares of Mastercard in a research note on Monday, March 10th. Seven research analysts have rated the stock with a hold rating, twenty-four have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Mastercard currently has a consensus rating of “Moderate Buy” and an average target price of $610.00.

Mastercard Stock Performance

Shares of MA stock opened at $532.18 on Friday. The company has a market cap of $485.19 billion, a price-to-earnings ratio of 37.32, a price-to-earnings-growth ratio of 2.35 and a beta of 1.05. Mastercard Incorporated has a 52 week low of $428.86 and a 52 week high of $594.71. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 2.81. The firm has a 50 day moving average of $559.72 and a 200-day moving average of $544.51.

Mastercard (NYSE:MA) last announced its quarterly earnings data on Thursday, May 1st. The credit services provider reported $3.73 EPS for the quarter, topping the consensus estimate of $3.57 by $0.16. Mastercard had a net margin of 45.21% and a return on equity of 196.87%. The company had revenue of $7.25 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter last year, the firm posted $3.31 EPS. The company’s quarterly revenue was up 14.2% on a year-over-year basis. On average, equities analysts forecast that Mastercard Incorporated will post 15.91 earnings per share for the current year.

About Mastercard

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company offers integrated products and value-added services for account holders, merchants, financial institutions, digital partners, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid programs services; and commercial credit, debit, and prepaid payment products and solutions.